The Senate passed a massive opioid bill 99-1, but public health experts and first responders are concerned it won’t do enough to stop the crisis; pharmaceutical companies with manufacturing plants in North Carolina, South Carolina, and Virginia put emergency plans in place last week as Hurricane Florence bore down to avoid shortages of drugs and vaccines; the cannabis industry is booming, and one of the fastest growing group of users are people over age 50.
The Senate passed a massive opioid bill 99-1, but public health experts and first responders are concerned it won’t do enough to stop the crisis, Politico reported. It does little to address the severe nationwide shortage of treatment beds for rehab or to encourage more doctors to prescribe medication to treat substance use disorder, which requires special training and licensing. The bills create new grants and demonstrations to test new treatment programs, but there is no permanent funding solution attached.
Pharmaceutical companies with manufacturing plants in North Carolina, South Carolina, and Virginia put emergency plans in place last week as Hurricane Florence bore down to avoid shortages of drugs and vaccines, STAT reported. GlaxoSmithKline closed a plant that makes asthma inhalers; Novartis shut down a facility that manufactures oral-dosage generic drugs; and Pfizer and Merck scaled back or closed operations at multiple North Carolina facilities. Besides the safety of employees, companies also sought to avoid the loss of drugs that would have hurt corporations’ bottom lines.
As more states legalize marijuana for medical or recreational use—30 states plus the District of Columbia to date—the cannabis industry is booming, and one of the fastest growing group of users are people over age 50, especially those 65 and older, Kaiser Health News reported. Kaiser profiled a retirement community in California where a medical marijuana dispensary sends a free shuttle bus to pick up senior citizens seeking relief from pain and other conditions.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More